Pharmacological Considerations and Complications - The Future of RA in ED
This talk by Dr Rabithoh was originally presented on the "Virtual Ultrasound Guided Regional Anesthesia 2021 - The Future of RA in ED" webinar on 20 November 2021. This online course was organized by the Emergency and Trauma Department of Hospital Kuala Lumpur, in collaboration with the Regional Anaesthesia team of Hospital Kuala Lumpur, with the main aim being to promote and educate on RA for use in the emergency department. Don't forget to subscribe, like, and share! Check out the ETD HKL YouTube channel here: https://www.youtube.com/c/EmergencyTraumaHospitalKualaLumpur
Suggested videos

Safety of Asleep Regional Anaesthesia (YouTube Edition)
MY Special Interest Group in Regional Anaesthesia · 17:59

Virtual Ultrasound Guided Regional Anesthesia 2021 - The Future of RA in ED (Full Livestream)
MY Special Interest Group in Regional Anaesthesia · 4:10:39

Regional Anaesthesia in Trauma (YouTube Edition)
MY Special Interest Group in Regional Anaesthesia · 18:17

Rheumatoid arthritis - causes, symptoms, diagnosis, treatment, pathology
Osmosis from Elsevier · 12:28

Opening, Upper Limb Blocks (Ultrasound Guided Regional Anaesthesia, Hospital Pulau Pinang 2022)
MY Special Interest Group in Regional Anaesthesia · 1:05:07

Reversing Rheumatoid Arthritis: Patient Interview
The Goldberg Tener Clinic · 4:08

Virtual Live Anaesthesia Workshop - Regional Anaesthesia for the Chest
MY Special Interest Group in Regional Anaesthesia · 1:41:06

Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Glucagon Receptor Agonist)
WAVE Plastic Surgery · 2:34

Virtual Regional Anaesthesia Workshop for Trauma and Emergency
MY Special Interest Group in Regional Anaesthesia · 2:04:11

76 🎬 Update 🚨 Regional Anesthesia in Patients on Antithrombotic & Thrombolytic Therapy 💉🩸
Anesthesia and Perioperative Medicine · 12:58

Regional Anesthesia for Hip Surgery
MY Special Interest Group in Regional Anaesthesia · 51:10

CEL-SCI Announces IDMC Conclusions From Interim Review of Phase III Head and Neck Cancer Trial Data
CorporateProfile · 3:13